As NF-κB signaling is regarded as a crucial signaling pathway involved in the chronic inflammation status of dystrophic muscle, we speculate that G3BP1 may contribute to cellular damage and progression of DMD and represent a potential therapeutic target for DMD. Here, NFKB1 is linked to Duchenne muscular dystrophy.